Trial intelligence / Profile preview

Autonomic stress during neonatal intubation under propofol in very preterm infants

2018-003233-14Phase 4Completed

Sponsor
CHU Saint-Etienne
Start
Aug 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of propofol in respiratory distress syndrome (RDS), sponsored by CHU Saint-Etienne. Primary endpoint: Real-time low-frequency heart rate variability. Started Aug 2018; status: completed.

02

Drugs

propofol
03

Conditions

respiratory distress syndrome (RDS)

Beyond the preview

Go deeper on 2018-003233-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2018-003233-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call